Catalyst Pharmaceuticals upgraded By: MarketMinute.com Stock News October 05, 2016 at 17:31 PM EDT Piper Jaffray upgraded Catalyst Pharmaceuticals Inc. (Nasdaq: CPRX) from a Neutral rating to an Overweight rating sending the stock price up 34 cents to close at $1.46. Related Stocks: Catalyst Pharm Inc